Price Alert

Verrica Pharmaceuticals I... (VRCA)

NASDAQ: VRCA · Real-Time Price · USD

6.48

0.33 (5.37%)

At close: Aug 15, 2025, 10:07 AM

Verrica Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	15.4M	29.59M	46.33M	22.96M	31.93M	48.94M	69.55M	84.31M	55.14M	59.95M	34.27M	32.47M	5.43M	10.41M	15.75M	20.44M	24.71M	44.1M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	6.98M	8.97M	11.5M	54.6M	59.05M	65.42M	43.59M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	4K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	376K	376K	859K	538K	453K	452K	452K	n/a	436K	369K	n/a	221K	469K	142K	n/a	264K	285K	947K
Receivables	17.37M	5.65M	77K	84K	10.21M	7.59M	4.42M	4.07M	173K	56K	487K	419K	218K	431K	n/a	n/a	n/a	11.5M
Inventory	2.52M	2.46M	2.46M	2.58M	2.7M	2.5M	1.02M	279K	n/a	n/a	-487K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.49M	1.77M	2.31M	2.56M	2.48M	2.34M	2.54M	3.07M	1.46M	3.09M	4.36M	3.52M	40M	40M	3.97M	3.66M	3.25M	n/a
Total Current Assets	36.78M	39.47M	51.18M	28.19M	47.32M	61.38M	77.53M	91.72M	56.78M	63.1M	39.12M	43.4M	57.34M	65.77M	74.33M	83.16M	93.37M	102.05M
Property-Plant & Equipment	1.95M	2.33M	2.58M	4.2M	4.24M	4.48M	3.62M	5.42M	4.99M	5.17M	5.61M	5.53M	5.63M	5.7M	5.8M	5.33M	5.37M	5.11M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.33M	2.7M	3.44M	4.74M	4.69M	4.93M	4.07M	5.42M	5.42M	5.54M	5.61M	5.75M	6.09M	5.84M	5.8M	5.6M	5.66M	6.06M
Total Assets	39.11M	42.18M	54.13M	32.93M	52.01M	66.31M	81.6M	97.15M	62.2M	68.64M	44.72M	49.15M	63.44M	71.62M	80.13M	88.76M	99.03M	108.1M
Account Payables	2.32M	1.44M	1.9M	966K	1.15M	2.53M	2.46M	1.93M	2.06M	575K	507K	137K	714K	531K	845K	904K	783K	878K
Deferred Revenue	481K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-291K	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	13.32M	12.82M	12.94M	n/a	n/a	1.01M	700K	347K	309K	n/a	297K	291K	42.29M	42M	41.69M	41.59M	41.25M	40.9M
Other Current Liabilities	11.25M	12.81M	11.59M	16.24M	15.51M	7.91M	9.72M	1.97M	1.94M	538K	1.1M	1.09M	291K	459K	255K	1.91M	1.92M	1.76M
Total Current Liabilities	29.22M	29.4M	29.01M	21.03M	20.05M	19.36M	17.02M	11.37M	5.73M	2.64M	3.46M	3.08M	45.71M	44.8M	46.05M	46.37M	45.28M	44.66M
Long-Term Debt	995K	27.81M	30.98M	43.3M	42.75M	42.85M	42.87M	42.4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	26.37M	2.39M	2.65M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	27.37M	31.36M	34.98M	45.95M	45.26M	45.43M	44.81M	43.47M	1.07M	1.15M	1.23M	1.3M	1.39M	1.4M	1.47M	1.53M	1.59M	1.63M
Total Liabilities	56.59M	60.75M	63.99M	66.98M	65.31M	64.8M	61.83M	54.84M	6.8M	3.79M	4.69M	4.38M	47.1M	46.2M	47.52M	47.9M	46.87M	46.29M
Total Debt	14.31M	42.43M	45.94M	47.11M	46.31M	46.44M	45.51M	43.82M	1.38M	1.45M	1.53M	1.59M	43.98M	43.65M	43.41M	43.12M	42.84M	42.53M
Common Stock	1K	9K	9K	5K	4K	4K	4K	4K	4K	4K	4K	4K	3K	3K	3K	3K	3K	3K
Retained Earnings	-316.56M	-316.77M	-307.03M	-290.82M	-267.96M	-250.78M	-230.45M	-205.83M	-181.03M	-170.04M	-163.45M	-157.52M	-157.6M	-147.44M	-138.97M	-129.43M	-116.6M	-104.82M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.00	n/a	n/a	-29K	-64K	-62K	-29K	-2K	-1K	3K
Shareholders Equity	-17.48M	-18.58M	-9.86M	-34.05M	-13.3M	1.51M	19.76M	42.3M	55.4M	64.85M	40.03M	44.77M	16.33M	25.42M	32.6M	40.85M	52.16M	61.81M
Total Investments	n/a	n/a	n/a	n/a	n/a	4K	n/a	n/a	n/a	n/a	n/a	6.98M	8.97M	11.5M	54.6M	59.05M	65.42M	43.59M